Patients with CMV infection had significantly higher plasmatic CXCL-10 concentrations than CMV-free patients (p<0.01) (Figure 2D), reaching similar levels to those observed in patients with rejection. The gene discussed is CXCL10; the disease is cytomegalovirus infection.